Health Care Providers & Services (18) | Intellectual Property (18)
Browse by Subcategory
Browse by Company
Recent Contracts
-
Patent and License Technology Agreement
(CRYO CELL INTERNATIONAL INC, Filed With SEC on April 14, 2021)
-
Blue Shield License Agreement by and between Blue Cross Blue Shield Association and the Company, including revisions, if any, adopted by the Member Plans through September 17, 2020
(Anthem, Filed With SEC on February 18, 2021)
-
Blue Cross License Agreement by and between Blue Cross Blue Shield Association and the Company, including revisions, if any, adopted by the Member Plans through September 17, 2020
(Anthem, Filed With SEC on February 18, 2021)
-
License Agreement dated as of September 30, 2020
(Wellness Center USA, Inc., Filed With SEC on October 6, 2020)
-
First Amendment to Cloud DX Perpetual Software License Agreement dated March 6, 2020 and entered into on March 9, 2020
(Novo Integrated Sciences, Inc., Filed With SEC on March 12, 2020)
-
First Amendment to Master Facility License Agreement dated February 4, 2020 by and between Novomerica Health Group Inc. and Fitness International, LLC
(Novo Integrated Sciences, Inc., Filed With SEC on February 10, 2020)
-
First Amendment to Master Facility License Agreement dated February 4, 2020 by and between Novo Healthnet Limited, Inc. and LAF Canada Company
(Novo Integrated Sciences, Inc., Filed With SEC on February 10, 2020)
-
Master Facility License Agreement dated September 24, 2019 by and between Novomerica Health Group Inc., Fitness International, LLC, and Fitness & Sports Clubs, LLC
(Novo Integrated Sciences, Inc., Filed With SEC on September 30, 2019)
-
Master Facility License Agreement dated September 24, 2019 by and between Novo Healthnet Limited, Inc. and LAF Canada Company
(Novo Integrated Sciences, Inc., Filed With SEC on September 30, 2019)
-
Third Amendment to Amended and Restated Exclusive License Agreement, dated June 24, 2016, by and between the University of PittsburghOf the Commonwealth System of Higher Education...
(EXAGEN INC., Filed With SEC on August 23, 2019)